Neuroone Medical Technologies is trading at $1.71, up +6.45%, with no identified company-specific announcement on September 2, 2026; the gain appears inconclusive rather than tied to a confirmed catalyst.
- Fiscal Q3 results released in August showed 16% revenue growth and 43% higher product orders.
- Results also showed wider losses and reduced revenue visibility.
- Healthcare and major indexes are also higher.